Roche stakes $700M on Nurix’s protein-degrading drug

Yahoo Finance·Jun 8

This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Roche enters $2 billion cancer drug agreement with Nurix Therapeutics

Yahoo Finance·Jun 8

2

Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics

Yahoo Finance·Jun 8

3

Roche bets $700M upfront on Nurix’s late-phase BTK degrader to tee up Lilly showdown

Fierce Biotech·Jun 8

4

Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg

Pharmaceutical Executive·Jun 8

5

Roche bets on BTK degradation in $2.3bn Nurix deal

European Biotechnology Magazine·Jun 8

6

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Yahoo Finance·Jun 7

7

Myeloma cell therapies, now in pharma hands, move into spotlight

BioPharma Dive·Dec 7